GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Carasent ASA (OSL:CARA) » Definitions » EV-to-EBITDA

Carasent ASA (OSL:CARA) EV-to-EBITDA : 140.88 (As of Jun. 08, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Carasent ASA EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Carasent ASA's enterprise value is kr983.9 Mil. Carasent ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr7.0 Mil. Therefore, Carasent ASA's EV-to-EBITDA for today is 140.88.

The historical rank and industry rank for Carasent ASA's EV-to-EBITDA or its related term are showing as below:

OSL:CARA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -329.87   Med: 6.96   Max: 2070.99
Current: 140.89

During the past 13 years, the highest EV-to-EBITDA of Carasent ASA was 2070.99. The lowest was -329.87. And the median was 6.96.

OSL:CARA's EV-to-EBITDA is ranked worse than
98.06% of 463 companies
in the Healthcare Providers & Services industry
Industry Median: 12.84 vs OSL:CARA: 140.89

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), Carasent ASA's stock price is kr18.10. Carasent ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.740. Therefore, Carasent ASA's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Carasent ASA EV-to-EBITDA Historical Data

The historical data trend for Carasent ASA's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carasent ASA EV-to-EBITDA Chart

Carasent ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.16 -83.54 75.11 10.05 164.40

Carasent ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.03 26.11 67.88 164.40 72.74

Competitive Comparison of Carasent ASA's EV-to-EBITDA

For the Health Information Services subindustry, Carasent ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carasent ASA's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Carasent ASA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Carasent ASA's EV-to-EBITDA falls into.



Carasent ASA EV-to-EBITDA Calculation

Carasent ASA's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=983.927/6.984
=140.88

Carasent ASA's current Enterprise Value is kr983.9 Mil.
Carasent ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carasent ASA  (OSL:CARA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Carasent ASA's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.10/-0.740
=At Loss

Carasent ASA's share price for today is kr18.10.
Carasent ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.740.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Carasent ASA EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Carasent ASA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Carasent ASA (OSL:CARA) Business Description

Traded in Other Exchanges
Address
Ovre Slottsgate 2B, Oslo, NOR, 0157
Carasent ASA is an investment management company that provides services to businesses that develop entrepreneurial and e-health solutions. The company has a system called 'Webdoc' a cloud-based medical record system with integrated add-on services for the private and public health care industry.

Carasent ASA (OSL:CARA) Headlines